1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-21
1 class of this one portfolio · 1 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000216720 | HELX | LINKEDSEC_TICKER | HELXFranklin Genomic Advancements ETF | ETF |
N-PORT Item C.4.a
N-PORT Item C.4.b
as filed
61 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| Guardant Health Inc Guardant Health Inc COM | GH | 40131M109 US40131M1099 | EC CORP | 15,718 NS | $1.45M | 6.770% | US |
| NATERA INC Natera Inc. COM | NTRA | 632307104 US6323071042 | EC CORP | 7,131 NS | $1.43M | 6.650% | US |
| Krystal Biotech Inc Krystal Biotech Inc COM | KRYS | 501147102 US5011471027 | EC CORP | 4,418 NS | $1.14M | 5.321% | US |
| United Therapeutics Corporation United Therapeutics Corporation COM | UTHR | 91307C102 US91307C1027 | EC CORP | 1,680 NS | $996.2K | 4.645% | US |
| Insmed Inc Insmed Inc COM PAR $.01 | INSM | 457669307 US4576693075 | EC CORP | 5,932 NS | $970.0K | 4.523% | US |
| Bridgebio Pharma Inc Bridgebio Pharma Inc COM | BBIO | 10806X102 US10806X1028 | EC CORP | 12,192 NS | $905.4K | 4.221% | US |
| Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated COM NEW | LGND | 53220K504 US53220K5048 | EC CORP | 3,794 NS | $757.5K | 3.532% | US |
| AstraZeneca PLC AstraZeneca PLC ORD USD0.25 | AZN | 000000000 GB0009895292 | EC CORP | 3,695 NS | $728.7K | 3.398% | GB |
| Adaptive Biotechnologies Corp Adaptive Biotechnologies Corp COM | ADPT | 00650F109 US00650F1093 | EC CORP | 48,245 NS | $669.6K | 3.122% | US |
| Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated COM | VRTX | 92532F100 US92532F1003 | EC CORP | 1,435 NS | $640.8K | 2.988% | US |
| Samsung Biologics Co Ltd Samsung Biologics Co Ltd KRW2500 | — | 000000000 KR7207940008 | EC CORP | 652 NS | $640.2K KRW | 2.985% | KR |
| Medpace Holdings Inc. Medpace Holdings Inc. COM | MEDP | 58506Q109 US58506Q1094 | EC CORP | 1,327 NS | $637.2K | 2.971% | US |
| Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. COM | REGN | 75886F107 US75886F1075 | EC CORP | 748 NS | $577.9K | 2.695% | US |
| Corteva Inc Corteva Inc COM | CTVA | 22052L104 US22052L1044 | EC CORP | 6,904 NS | $577.9K | 2.695% | US |
| Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals Inc. COM | ALNY | 02043Q107 US02043Q1076 | EC CORP | 1,687 NS | $558.2K | 2.603% | US |
| Eli Lilly & Co. Eli Lilly & Co. COM | LLY | 532457108 US5324571083 | EC CORP | 593 NS | $545.4K | 2.543% | US |
| Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. COM | IONS | 462222100 US4622221004 | EC CORP | 5,957 NS | $447.3K | 2.086% | US |
| Tempus AI Inc. Tempus AI Inc. CL A | TEM | 88023B103 US88023B1035 | EC CORP | 8,726 NS | $394.6K | 1.840% | US |
| BioNTech SE BioNTech SE SPONSORED ADS | BNTX | 09075V102 US09075V1026 | EC CORP | 4,340 NS | $385.7K | 1.799% | DE |
| Neurocrine Biosciences Inc Neurocrine Biosciences Inc COM | NBIX | 64125C109 US64125C1099 | EC CORP | 2,693 NS | $354.8K | 1.654% | US |
| Stoke Therapeutics Inc Stoke Therapeutics Inc COM | STOK | 86150R107 US86150R1077 | EC CORP | 10,539 NS | $343.1K | 1.600% | US |
| Twist Bioscience Corporation Twist Bioscience Corporation COM | TWST | 90184D100 US90184D1000 | EC CORP | 7,184 NS | $341.4K | 1.592% | US |
| Argenx SE Argenx SE EUR0.10 | — | 000000000 NL0010832176 | EC CORP | 459 NS | $328.3K EUR | 1.531% | NL |
| PTC Therapeutics, Inc. PTC Therapeutics, Inc. COM | PTCT | 69366J200 US69366J2006 | EC CORP | 4,652 NS | $316.9K | 1.478% | US |
| Travere Therapeutics Inc Travere Therapeutics Inc COM | TVTX | 89422G107 US89422G1076 | EC CORP | 10,129 NS | $300.9K | 1.403% | US |
| Charles River Laboratories International, Inc. Charles River Laboratories International, Inc… | CRL | 159864107 US1598641074 | EC CORP | 1,445 NS | $249.3K | 1.162% | US |
| CRISPR Therapeutics AG CRISPR Therapeutics AG NAMEN AKT | CRSP | 000000000 CH0334081137 | EC CORP | 4,671 NS | $222.2K | 1.036% | CH |
| Repligen Corporation Repligen Corporation COM | RGEN | 759916109 US7599161095 | EC CORP | 1,866 NS | $219.9K | 1.025% | US |
| Veracyte Inc Veracyte Inc COM | VCYT | 92337F107 US92337F1075 | EC CORP | 6,788 NS | $218.6K | 1.019% | US |
| Praxis Precision Medicines Inc Praxis Precision Medicines Inc COM NEW | PRAX | 74006W207 US74006W2070 | EC CORP | 667 NS | $214.9K | 1.002% | US |
| GRAIL Inc GRAIL Inc COM | GRAL | 384747101 US3847471014 | EC CORP | 4,138 NS | $213.9K | 0.997% | US |
| Sartorius AG Sartorius AG NON VTG PFD NPV | — | 000000000 DE0007165631 | EP CORP | 841 NS | $205.3K EUR | 0.957% | DE |
| Danaher Corporation Danaher Corporation COM | DHR | 235851102 US2358511028 | EC CORP | 1,050 NS | $199.1K | 0.928% | US |
| Thermo Fisher Scientific Inc Thermo Fisher Scientific Inc COM | TMO | 883556102 US8835561023 | EC CORP | 391 NS | $192.2K | 0.896% | US |
| IQVIA Holdings Inc. IQVIA Holdings Inc. COM | IQV | 46266C105 US46266C1053 | EC CORP | 1,005 NS | $171.4K | 0.799% | US |
| BEAM THERAPEUTICS INC Beam Therapeutics Inc. COM | BEAM | 07373V105 US07373V1052 | EC CORP | 7,036 NS | $167.7K | 0.782% | US |
| Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC SHS USD | JAZZ | 000000000 IE00B4Q5ZN47 | EC CORP | 841 NS | $159.0K | 0.741% | IE |
| Catalyst Pharmaceuticals Inc. Catalyst Pharmaceuticals Inc. COM | — | 14888U101 US14888U1016 | EC CORP | 6,375 NS | $157.8K | 0.736% | US |
| Cadence Design Systems, Inc. Cadence Design Systems, Inc. COM | CDNS | 127387108 US1273871087 | EC CORP | 545 NS | $151.4K | 0.706% | US |
| Agilent Technologies Inc. Agilent Technologies Inc. COM | A | 00846U101 US00846U1016 | EC CORP | 1,136 NS | $129.5K | 0.604% | US |
| Caredx Inc Caredx Inc COM | CDNA | 14167L103 US14167L1035 | EC CORP | 7,429 NS | $129.0K | 0.601% | US |
| QIAGEN NV QIAGEN NV ORD SHARES | QGEN | 000000000 NL0015002SN0 | EC CORP | 3,175 NS | $127.1K | 0.593% | NL |
| AnaptysBio Inc. AnaptysBio Inc. COM | ANAB | 032724106 US0327241065 | EC CORP | 2,041 NS | $113.2K | 0.528% | US |
| SAMSUNG EPIS HOLDINGS CO LTD Samsung Epis Holdings KRW2500 | — | 000000000 KR70126Z0002 | EC CORP | 350 NS | $112.9K KRW | 0.526% | KR |
| Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc COM | TARS | 87650L103 US87650L1035 | EC CORP | 1,487 NS | $104.3K | 0.486% | US |
| Ultragenyx Pharmaceuticals Inc Ultragenyx Pharmaceuticals Inc COM | RARE | 90400D108 US90400D1081 | EC CORP | 4,765 NS | $99.8K | 0.465% | US |
| ARCUTIS BIOTHERAPEUTICS INC Arcutis Biotherapeutics Inc. COM | ARQT | 03969K108 US03969K1088 | EC CORP | 4,107 NS | $96.8K | 0.451% | US |
| Axsome Therapeutics Inc. Axsome Therapeutics Inc. COM | AXSM | 05464T104 US05464T1043 | EC CORP | 566 NS | $95.7K | 0.446% | US |
| GeneDx Holdings Corp GeneDx Holdings Corp COM CL A | WGS | 81663L200 US81663L2007 | EC CORP | 1,409 NS | $90.5K | 0.422% | US |
| Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc COM | RYTM | 76243J105 US76243J1051 | EC CORP | 974 NS | $84.7K | 0.395% | US |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 92.9% of reported value reaches a classification.
Percentages are of the reported value of positions above ($20.80M), not of the fund’s net assets ($21.45M). The two differ by cash, derivatives filed with no market value, and rounding.